Related Experiment Video
Updated: Jun 17, 2025
10:37
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
108
Integrated Transcriptomics and Proteomics Identified CMPK1 as a Potential Biomarker for Type 2 Diabetes Mellitus
Summary
Cytidylate kinase 1 (CMPK1) is upregulated in the livers of obese patients with type 2 diabetes mellitus (T2DM). This finding offers a potential new biomarker for diagnosing T2DM in obese individuals and understanding metabolic disease mechanisms.
Area of Science:
- Metabolomics
- Proteomics
- Biomarker Discovery
Background:
- Type 2 diabetes mellitus (T2DM) is a prevalent global disease, with obesity being a major risk factor.
- The precise mechanisms linking obesity to T2DM pathogenesis remain unclear.
- Identifying reliable biomarkers for diagnosing and managing obese T2DM patients is crucial.
Purpose of the Study:
- To identify novel protein biomarkers associated with T2DM in obese individuals.
- To elucidate the role of these biomarkers in the pathophysiology of obesity-related metabolic diseases.
- To validate potential diagnostic and therapeutic targets for T2DM.
Main Methods:
- Proteomic sequencing and immunohistochemistry on liver tissues from obese patients with and without T2DM.
- Bioinformatic analyses including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.
- Integration of proteomic data with transcriptome data from the Gene Expression Omnibus (GEO) database.
Main Results:
- 140 differentially expressed proteins were identified; six showed consistent changes in both proteome and transcriptome.
- Cytidylate kinase 1 (CMPK1) was identified as a core protein among the six biomarkers, showing the greatest differential expression.
- Immunohistochemistry confirmed significant upregulation of CMPK1 in the livers of T2DM patients, with correlations to T2DM-related pathways.
Conclusions:
- CMPK1 is upregulated in the liver of T2DM patients, suggesting its potential as a biomarker for T2DM screening and diagnosis in obese populations.
- This study provides a novel theoretical basis for understanding the pathophysiological mechanisms of obesity-related metabolic diseases.
- CMPK1 represents a potential new target for the diagnosis and treatment of T2DM.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:36Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:58Cell Specific Gene Expression
13.5K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.5K